Genomic Medicine Initiative

Department of Pathology


Information about our faculty and staff.

Ramy Arnaout, M.D., D.Phil.

Dr. Ramy Arnaout is a practicing pathologist and systems biologist in the Department of Pathology at the Beth Israel-Deaconess Medical Center in Boston. He completed residency in Clinical Pathology at Brigham and Women’s Hospital and is currently Associate Director of the Clinical Microbiology Laboratory at BIDMC. He received his MD from Harvard Medical School, where he was a Soros Fellow, and his PhD from the University of Oxford, where he was a Marshall Scholar. He is interested in how mathematical and computational and systems analysis can help clinical information be better used for patient care.

Andrew H. Beck, M.D.

Dr. Andrew Beck is an Assistant Professor of Pathology at Harvard Medical School and Director of the Molecular Epidemiology Research Laboratory at Beth Israel Deaconess Medical Center. Prior to joining BIDMC, he completed graduate training in Biomedical Informatics, residency in Anatomic Pathology, and a clinical fellowship in Molecular Genetic Pathology at Stanford University. His research is focused on developing and applying methods in biomedical informatics and molecular pathology to problems in genomic medicine, with a focus on cancer.

Mark S. Boguski, M.D., Ph.D., FCAP

Dr. Mark Boguski is on the faculty of Harvard Medical School and Beth Israel Deaconess Medical Center in Boston where he founded the Genomic Medicine Initiative in 2009. Dr. Boguski is a pioneer in the fields of bioinformatics and genomics and has previously held faculty positions at the Johns Hopkins University School of Medicine, the U.S. National Institutes of Health, the U.S. National Library of Medicine and as an executive in the biotechnology and pharmaceutical industries. He is a former vice president of Novartis and a Visionary and Influencer according to the Personalized Medicine Coalition. Boguski is a member of the Institute of Medicine of the U.S. National Academies, the American College of Medical Informatics, the Society for Participatory Medicine and is also a Fellow of the College of American Pathologists. He is a graduate of the Medical Scientist Training Program at Washington University in St. Louis.


Lauren Briere, M.S.

Lauren Briere is a genetic counselor who earned her masters degree in genetic counseling from the University of California, Irvine, in 2006. She is certified by the American Board of Genetic Counseling and licensed by the Commonwealth of Massachusetts’ Department of Public Health. Ms. Briere has worked as a genetic counselor in the Department of Obstetrics and Gynecology’s Division of Genetics at Beth Israel Deaconess Medical Center since 2006.

Richard Haspel, M.D., Ph.D.

Dr. Richard Haspel completed a residency in Clinical Pathology at Brigham and Women’s Hospital and a fellowship in Transfusion Medicine at Massachusetts General Hospital. He is currently the Medical Director of the Stem Cell Processing Laboratory as well as the Director of the Laboratory Medicine Residency Training Program at Beth Israel Deaconess Hospital. He has completed two year-long Harvard University Rabkin fellowships in medical education and has an interest in curricular design on both the undergraduate and graduate levels.

Karen Marchand, M.S.

Karen Marchand is a Licensed Genetic Counselor in the Clinical Genetics Program within the Department of Obstetrics and Gynecology at Beth Israel Deaconess Medical Center in Boston. She has been at BIDMC since 2003. Ms. Marchand received her B.A. degree in Biology from Colby College and earned her Master’s degree in Genetic Counseling from Brandeis University. She is certified by the American Board of Genetic Counseling (ABGC). Prior to her position at BIDMC she worked as a laboratory technician in Dr. Philip Leder’s lab in the Department of Genetics at Harvard Medical School.

Peter J. Tonellato, Ph.D.

Dr. Peter Tonellato is on the faculty of Harvard Medical School at the Center for Biomedical Informatics and the Department of Pathology at Beth Israel Deaconess Medical Center in Boston and at the School of Public Health, University of Wisconsin, Milwaukee, WI. Past affiliations include the Department of Mathematics, Marquette University and the Bioinformatics Research Center, Medical College of Wisconsin. Dr. Tonellato founded and was Chairman of POINTONE, a personalized medicine software company that provided genetic enabled ‘best practice’ decision support system to hospitals and health care facilities. Dr. Tonellato created and was P.I. of the Rat Genome Database, a disease-centric repository of phenotype and genetic data. Dr. Tonellato is the director of the Laboratory for Personalized Medicine a joint (Harvard Medical School, Beth Israel Deaconess Medical Center, School of Public Health, UWM) lab developing strategies, methods, bioinformatic tools, and analyses to study and test the accuracy and clinical efficacy of genetic discoveries and accelerate their translation to practical clinical use.

Dennis P. Wall, Ph.D.

Dr. Dennis Wall is Assistant Professor of Pediatrics and Director of the Computational Biology Initiative at Harvard Medical School, where his lab is developing novel approaches in systems biology to decipher the molecular pathology of autism spectrum disorder and related neurological disease. Dr. Wall received his doctorate in Integrative Biology from the University of California, Berkeley, where he pioneered the use of fast evolving gene sequences to trace population-scale diversification across islands. Then, with a postdoctoral fellowship award from the National Science Foundation, he went on to Stanford University to address broader questions in systems biology and computational genomics, work that resulted in comprehensive functional models for both protein mutation and protein interaction. Since joining the faculty at the Center for Biomedical Informatics at Harvard Medical School in 2006, he has been translating systems biology thinking to the field of autism research with the intent to develop effective early-stage diagnostics and targets for therapeutic intervention. Dr. Wall has acted as science advisor to several biotechnology and pharmaceutical companies, has developed cutting-edge approaches to cloud computing, and has received numerous awards, including an NSF postdoctoral fellowship, the Fred R. Cagle Award for Outstanding Achievement in Biology, the Vice Chancellor’s Award for Research, three awards for excellence in teaching, and the Harvard Medical School Leadership award.